Department of Cardiology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Gusu School, Nanjing Medical University, Suzhou, China.
Lipids Health Dis. 2022 Mar 18;21(1):30. doi: 10.1186/s12944-022-01638-6.
Elevated monocyte-to-high-density lipoprotein-cholesterol ratio (MHR) is relevant to higher all-cause and cardiovascular mortality in patients with coronary artery disease and other comorbidities. However, the predictive values of MHR for mortality in the general population have been underutilized. This study investigated the association of MHR with all-cause and cardiovascular mortality in the adult population of the United States.
This study included 34,335 participants (≥20 years) from the National Health and Nutrition Examination Survey 1999-2014 that were grouped according to MHR tertiles. Kaplan-Meier plots and long-rank tests were employed to investigate differences in survival among the groups. Moreover, the relationship of MHR with all-cause and cardiovascular mortality was further explored using multivariate Cox regression and restricted cubic spline analysis.
During the average follow-up of 93.5 ± 56 months, 4310 (12.6%) participants died, with 754 (2.2%) deaths attributed to cardiovascular diseases. Kaplan-Meier analysis revealed statistically obvious differences in all-cause and cardiovascular mortality among the MHR tertiles (log-rank test: all P < 0.001). In multi-adjusted models, participants in the highest tertile of MHR had an increased risk of all-cause (hazard ratio [HR] = 1.19, 95% confidence interval [CI] 1.10-1.29) and cardiovascular mortality (HR = 1.44, 95% CI 1.17-1.77), compared to those in the lowest tertile. Furthermore, the restricted cubic spline curve indicated that MHR had a non-linear association with all-cause mortality (P < 0.001), and the inflection point of MHR was 0.006. Each 2-fold change in MHR exhibited a 32% decrease (HR = 0.68, 95%CI 0.58-0.82) and a 20% increase (HR = 1.20, 95%CI 1.13-1.27) in the risk of all-cause mortality on the left and right flanks of the inflection point, respectively. Additionally, the risk of cardiovascular mortality increased by 21% per 2-fold change in MHR (HR = 1.21, 95%CI 1.07-1.36) in a linear manner.
MHR was significantly related to all-cause and cardiovascular mortality in the general population independent of established risk factors.
单核细胞-高密度脂蛋白胆固醇比值(MHR)升高与冠心病及其他合并症患者的全因和心血管死亡率升高相关。然而,MHR 对普通人群死亡率的预测价值尚未得到充分利用。本研究旨在探讨 MHR 与美国成年人全因和心血管死亡率的关系。
本研究纳入了 1999-2014 年国家健康与营养调查(NHANES)中 34335 名(≥20 岁)参与者,并根据 MHR 三分位将其分组。采用 Kaplan-Meier 图和对数秩检验比较各组之间的生存差异。此外,还采用多变量 Cox 回归和限制三次样条分析进一步探讨 MHR 与全因和心血管死亡率的关系。
在平均 93.5±56 个月的随访期间,4310 名(12.6%)参与者死亡,其中 754 名(2.2%)死于心血管疾病。Kaplan-Meier 分析显示,MHR 三分位组之间的全因和心血管死亡率存在统计学差异(对数秩检验:均 P<0.001)。在多因素调整模型中,MHR 最高三分位组的全因死亡风险(HR=1.19,95%CI 1.10-1.29)和心血管死亡风险(HR=1.44,95%CI 1.17-1.77)均高于最低三分位组。此外,限制三次样条曲线表明,MHR 与全因死亡率之间存在非线性关系(P<0.001),MHR 的拐点为 0.006。MHR 每增加 2 倍,全因死亡率的风险分别降低 32%(HR=0.68,95%CI 0.58-0.82)和升高 20%(HR=1.20,95%CI 1.13-1.27),拐点左侧和右侧的风险分别降低 32%和升高 20%。此外,MHR 每增加 2 倍,心血管死亡率的风险线性增加 21%(HR=1.21,95%CI 1.07-1.36)。
MHR 与普通人群的全因和心血管死亡率显著相关,独立于已确定的危险因素。